Krystin A. Bedard

The Histone Deacetylase Inhibitor, Vorinostat, Reduces Tumor Growth at the Metastatic Bone Site and Associated Osteolysis, but Promotes Normal Bone Loss

G. Stein, J. Lian, A. V. van Wijnen, 2010, Molecular Cancer Therapeutics.

Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.

C. Bedrosian, A. Kukreja, S. Faas, 2015, Blood.

Runx2 Association with Progression of Prostate Cancer in Patients: Mechanisms Mediating Bone Osteolysis and Osteoblastic Metastatic Lesions

G. Stein, J. Lian, A. V. van Wijnen, 2009, Oncogene.